Medtronic PLC financials
Key figures from Medtronic PLC's filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Jul 2026 | Jul 2025 | Change |
|---|---|---|---|
| Revenue | $9.8B | $8.6B | +13.7% |
| Net income | $1.5B | $1.0B | +41.3% |
| Free cash flow | $1.3B | $584M | +120.9% |
| Gross margin | 65.0% | 65.0% | -0.0 pts |
| Operating margin | 18.1% | 16.8% | +1.2 pts |
| Net margin | 15.1% | 12.1% | +2.9 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Apr 2026 | $36.4B | $4,801 | 0.0% | $5.4B | $3.73 |
| FY Apr 2025 | $33.5B | $4,662 | 0.0% | $5.2B | $3.61 |
| FY Apr 2024 | $32.4B | $3,676 | 0.0% | $5.2B | $2.76 |
| FY Apr 2023 | $31.2B | $3,758 | 0.0% | $4.6B | $2.82 |
| FY Apr 2022 | $31.7B | $5,039 | 0.0% | $6.0B | $3.73 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.